We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$19.6B
AUM Growth
-$1.06B
Cap. Flow
-$252M
Cap. Flow %
-1.29%
Top 10 Hldgs %
27.73%
Holding
2,867
New
60
Increased
922
Reduced
1,499
Closed
102

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$62.3M
2
SPHY icon
State Street SPDR Portfolio High Yield Bond ETF
SPHY
+$39.5M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.8M
4
AZN icon
AstraZeneca
AZN
+$28.4M
5
SSB icon
SouthState Bank Corp
SSB
+$27.1M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$32.2M
2
NVDA icon
NVIDIA
NVDA
+$28.8M
3
SNV
Synovus
SNV
+$21M
4
AUB icon
Atlantic Union Bankshares
AUB
+$20.5M
5
MSFT icon
Microsoft
MSFT
+$20M

Sector Composition

Rank Sector Weight
1 Technology 28.46%
2 Financials 12.71%
3 Industrials 10.47%
4 Healthcare 10.16%
5 Consumer Discretionary 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAA icon
1901
PRA Group
PRAA
$672M
$368K ﹤0.01%
21,051
+1,992
+10% +$30.3K
HTBK
1902
DELISTED
Heritage Commerce
HTBK
$367K ﹤0.01%
29,398
-1,840
-6% -$23.4K
CXM icon
1903
Sprinklr
CXM
$1.51B
$366K ﹤0.01%
61,011
+2,774
+5% +$17.2K
ODC icon
1904
Oil-Dri
ODC
$1.43B
$366K ﹤0.01%
5,621
– –
SMBK icon
1905
SmartFinancial
SMBK
$906M
$366K ﹤0.01%
9,359
+748
+9% +$29.6K
BCAX
1906
Bicara Therapeutics
BCAX
$1.7B
$365K ﹤0.01%
18,360
-3,159
-15% -$54.4K
ABUS icon
1907
Arbutus Biopharma
ABUS
$847M
$365K ﹤0.01%
81,069
+7,833
+11% +$34.3K
COTY icon
1908
Coty
COTY
$2.4B
$365K ﹤0.01%
181,418
+2,287
+1% +$6.15K
AVNS icon
1909
Avanos Medical
AVNS
$364K ﹤0.01%
26,010
– –
OWL icon
1910
Blue Owl Capital
OWL
$6.45B
$364K ﹤0.01%
39,882
-1,120
-3% -$13.5K
SMBC icon
1911
Southern Missouri Bancorp
SMBC
$862M
$364K ﹤0.01%
5,694
+245
+4% +$15.3K
JANX icon
1912
Janux Therapeutics
JANX
$912M
$362K ﹤0.01%
26,031
+2,155
+9% +$29.5K
CLOV icon
1913
Clover Health Investments
CLOV
$2.23B
$361K ﹤0.01%
205,352
-6,090
-3% -$13.2K
AMPL icon
1914
Amplitude
AMPL
$1.18B
$359K ﹤0.01%
52,663
+1,322
+3% +$10.9K
GBTG icon
1915
American Express Global Business Travel
GBTG
$4.92B
$358K ﹤0.01%
64,197
-8,932
-12% -$55.5K
OIS icon
1916
Oil States International
OIS
$466M
$358K ﹤0.01%
30,731
+5,182
+20% +$53.5K
CNXN icon
1917
PC Connection
CNXN
$2.09B
$355K ﹤0.01%
6,069
-920
-13% -$55K
SWBI icon
1918
Smith & Wesson
SWBI
$649M
$354K ﹤0.01%
24,689
+7,038
+40% +$85.5K
TK icon
1919
Teekay
TK
$996M
$354K ﹤0.01%
28,957
+4,462
+18% +$49.2K
EGY icon
1920
Vaalco Energy
EGY
$562M
$353K ﹤0.01%
55,701
+12,563
+29% +$63.3K
STAA icon
1921
STAAR Surgical
STAA
$1.19B
$353K ﹤0.01%
18,879
-10,948
-37% -$209K
WASH icon
1922
Washington Trust Bancorp
WASH
$748M
$353K ﹤0.01%
10,542
+895
+9% +$29.5K
INBX icon
1923
Inhibrx
INBX
$1.16B
$352K ﹤0.01%
5,240
-80
-2% -$5.93K
PGC icon
1924
Peapack-Gladstone Financial
PGC
$815M
$352K ﹤0.01%
9,998
– –
METC icon
1925
Ramaco Resources Class A
METC
$629M
$351K ﹤0.01%
22,732
-407
-2% -$7.21K
75 76
77
78 79

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return

MetLife Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, MetLife Investment Management held 2,867 positions worth $19.6B, down 5.1% from $20.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

MetLife Investment Management's Q1 2026 filing shows 60 new, 922 increased, 1,499 reduced and 102 closed positions. Its largest new stake was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M. The largest sale was Apple, an estimated $32.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.

  • MetLife Investment Management's largest Q1 2026 buy was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $62.3M increase.
  • MetLife Investment Management's biggest Q1 2026 reduction was Apple, cutting an estimated $32.2M.
  • MetLife Investment Management fully exited Synovus in Q1 2026, selling an estimated $21M.
  • MetLife Investment Management's ten largest holdings make up 28% of its $19.6B portfolio in Q1 2026.
  • MetLife Investment Management opened 60 new positions and closed 102 in Q1 2026.
  • MetLife Investment Management's portfolio value fell 5.1% quarter-over-quarter to $19.6B.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.